Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-Daily Versus Twice-Daily Insulin Glargine in Pregestational Diabetes
NCT07224893Phase 4Recruiting
- Sponsor
- Eastern Virginia Medical School
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Eastern Virginia Medical School. Started May 2026; status: recruiting.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07224893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224893.